Lonza Group AG (LZAGY)

Market Cap	44.92B -3.0%
Revenue (ttm)	8.24B -0.7%
Net Income	1.20B +49.2%
EPS	17.04 +51.5%
Shares Out	n/a
PE Ratio	37.53
Forward PE	27.19
Dividend	0.30 (0.47%)
Ex-Dividend Date	May 14, 2025

Volume	74,661
Average Volume	155,818
Open	65.11
Previous Close	64.61
Day's Range	63.02 - 65.11
52-Week Range	55.57 - 73.85
Beta	0.94
RSI	34.75
Earnings Date	Apr 1, 2026

About Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substanc...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1897
• Employees: 19,771
• Stock Exchange: OTCMKTS
• Ticker Symbol: LZAGY

Financial Performance

In 2025, Lonza Group AG's revenue was 6.53 billion, a decrease of -0.65% compared to the previous year's 6.57 billion. Earnings were 949.00 million, an increase of 49.21%.

Financial numbers in CHF